Free Trial

Galapagos (GLPG) Stock Forecast & Price Target

Galapagos logo
$26.89 -0.23 (-0.85%)
(As of 09:57 AM ET)

Galapagos - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
5
Buy
0

Based on 7 Wall Street analysts who have issued ratings for Galapagos in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 7 analysts, 2 have given a sell rating, and 5 have given a hold rating for GLPG.

Consensus Price Target

$30.75
14.35% Upside
According to the 7 analysts' twelve-month price targets for Galapagos, the average price target is $30.75. The highest price target for GLPG is $38.00, while the lowest price target for GLPG is $24.00. The average price target represents a forecasted upside of 14.35% from the current price of $26.89.
Get the Latest News and Ratings for GLPG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Galapagos and its competitors.

Sign Up

GLPG Analyst Ratings Over Time

TypeCurrent Forecast
12/19/23 to 12/18/24
1 Month Ago
11/19/23 to 11/18/24
3 Months Ago
9/20/23 to 9/19/24
1 Year Ago
12/19/22 to 12/19/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$30.75$30.75$31.00$43.40
Forecasted Upside14.35% Upside13.89% Upside1.84% Upside9.60% Upside
Consensus Rating
Reduce
Reduce
Reduce
Hold

GLPG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GLPG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Galapagos Stock vs. The Competition

TypeGalapagosMedical CompaniesS&P 500
Consensus Rating Score
1.71
2.81
2.51
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside13.38% Upside28,647.27% Upside12.03% Upside
News Sentiment Rating
Neutral News

See Recent GLPG News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/20/2024Kepler Capital Markets
4 of 5 stars
 DowngradeHold ➝ Reduce
11/1/2024Royal Bank of Canada
4 of 5 stars
 Lower TargetSector Perform ➝ Sector Perform$32.00 ➝ $30.00+11.36%
9/9/2024Leerink Partnrs
5 of 5 stars
F. Khurshid
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
9/9/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$24.00-12.98%
8/2/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Mccutcheon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
4/22/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$38.00 ➝ $38.00+29.34%
3/28/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Underperform$41.00 ➝ $31.00-5.92%
8/24/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
5/31/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
5/31/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral
1/23/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Hold$49.00 ➝ $47.20+3.01%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:27 AM ET.


GLPG Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Galapagos is $30.75, with a high forecast of $38.00 and a low forecast of $24.00.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Galapagos in the last twelve months. There are currently 2 sell ratings and 5 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" GLPG shares.

According to analysts, Galapagos's stock has a predicted upside of 14.35% based on their 12-month stock forecasts.

Over the previous 90 days, Galapagos's stock had 1 downgrade by analysts.

Galapagos has been rated by research analysts at Kepler Capital Markets, and Royal Bank of Canada in the past 90 days.

Analysts like Galapagos less than other "medical" companies. The consensus rating for Galapagos is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how GLPG compares to other companies.


This page (NASDAQ:GLPG) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners